These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11131675)

  • 1. Chemokines and anti-cancer immunotherapy: anti-tumor effect of EBI1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC).
    Nomura T; Hasegawa H
    Anticancer Res; 2000; 20(6A):4073-80. PubMed ID: 11131675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
    Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
    Sharma S; Stolina M; Zhu L; Lin Y; Batra R; Huang M; Strieter R; Dubinett SM
    Cancer Res; 2001 Sep; 61(17):6406-12. PubMed ID: 11522634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy.
    Kirk CJ; Hartigan-O'Connor D; Nickoloff BJ; Chamberlain JS; Giedlin M; Aukerman L; Mule JJ
    Cancer Res; 2001 Mar; 61(5):2062-70. PubMed ID: 11280767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is secondary lymphoid-organ chemokine (SLC/CCL21) much more than a constitutive chemokine?
    Serra HM; Baena-Cagnani CE; Eberhard Y
    Allergy; 2004 Nov; 59(11):1219-23. PubMed ID: 15461605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues.
    Nagira M; Sato A; Miki S; Imai T; Yoshie O
    Virology; 1999 Nov; 264(2):422-6. PubMed ID: 10562503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
    Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
    J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
    Westermann J; Nguyen-Hoai T; Baldenhofer G; Höpken UE; Lipp M; Dörken B; Pezzutto A
    Cancer Gene Ther; 2007 Jun; 14(6):523-32. PubMed ID: 17384577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
    Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL
    Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice.
    Warren P; Song W; Holle E; Holmes L; Wei Y; Li J; Wagner T; Yu X
    Anticancer Res; 2002; 22(2A):599-604. PubMed ID: 12014627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble expression of recombinant human secondary lymphoid chemokine (SLC) in E. coli and research on its in vitro and in vivo bioactivity.
    Chun L; Yin CC; Song JZ; Liu MX; Piao JH; Lin Q; Wang XB; Huang HL
    J Biochem; 2004 Dec; 136(6):769-76. PubMed ID: 15671487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model.
    Yamashita N; Tashimo H; Matsuo Y; Ishida H; Yoshiura K; Sato K; Yamashita N; Kakiuchi T; Ohta K
    J Allergy Clin Immunol; 2006 May; 117(5):1040-6. PubMed ID: 16675330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
    Yang SC; Batra RK; Hillinger S; Reckamp KL; Strieter RM; Dubinett SM; Sharma S
    Cancer Res; 2006 Mar; 66(6):3205-13. PubMed ID: 16540672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
    Ebert LM; Schaerli P; Moser B
    Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21.
    Yamano T; Kaneda Y; Hiramatsu SH; Huang S; Tran AN; Giuliano AE; Hoon DS
    Cancer Gene Ther; 2007 May; 14(5):451-9. PubMed ID: 17318199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes.
    Nomura T; Hasegawa H; Kohno M; Sasaki M; Fujita S
    Int J Cancer; 2001 Mar; 91(5):597-606. PubMed ID: 11267967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.
    Hisada M; Yoshimoto T; Kamiya S; Magami Y; Miyaji H; Yoneto T; Tamada K; Aoki T; Koyanagi Y; Mizuguchi J
    Cancer Gene Ther; 2004 Apr; 11(4):280-8. PubMed ID: 15002032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
    Alt C; Laschinger M; Engelhardt B
    Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs.
    Veerman KM; Williams MJ; Uchimura K; Singer MS; Merzaban JS; Naus S; Carlow DA; Owen P; Rivera-Nieves J; Rosen SD; Ziltener HJ
    Nat Immunol; 2007 May; 8(5):532-9. PubMed ID: 17401367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.